Marizomib: A novel therapeutic approach for the treatment of central nervous system myeloma

被引：2

作者：

Bazou, Despina ^{[1
]}

Le, Giao ^{[1
]}

Boyle, Aoife ^{[1
]}

Blum, Agnieszka ^{[1
]}

O'Gorman, Peter ^{[1
]}

机构：

[1] Mater Misericordiae Univ Hosp, Dept Haematol, Dublin 7, Ireland

来源：

EJHAEM | 2020年 / 1卷 / 01期

关键词：

MULTIPLE-MYELOMA;

D O I：

10.1002/jha2.72

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：315 / 317

页数：3

共 10 条

[1] Marizomib for central nervous system-multiple myeloma [J].

Badros, Ashraf ;

Singh, Zeba ;

Dhakal, Binod ;

Kwok, Young ;

MacLaren, Ann ;

Richardson, Paul ;

Trikha, Mohit ;

Hari, Parameswaran .

BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (02) :221-225

[2] Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents [J].

Chen, Christine I. ;

Masih-Khan, Esther ;

Jiang, Haiyan ;

Rabea, Ahmed ;

Cserti-Gazdewich, Christine ;

Jimenez-Zepeda, Victor H. ;

Chu, Chia-Min ;

Kukreti, Vishal ;

Trudel, Suzanne ;

Tiedemann, Rodger ;

Tsang, Richard ;

Reece, Donna E. .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) :483-488

[3] Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier [J].

Di, Kaijun ;

Lloyd, G. Kenneth ;

Abraham, Vivek ;

MacLaren, Ann ;

Burrows, Francis J. ;

Desjardins, Annick ;

Trikha, Mohit ;

Bota, Daniela A. .

NEURO-ONCOLOGY, 2016, 18 (06) :840-848

[4] Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations [J].

Fassas, ABT ;

Muwalla, F ;

Berryman, T ;

Benramdane, R ;

Joseph, L ;

Anaissie, E ;

Sethi, R ;

Desikan, R ;

Siegel, D ;

Badros, A ;

Toor, A ;

Zangari, M ;

Morris, C ;

Angtuaco, E ;

Mathew, S ;

Wilson, C ;

Hough, A ;

Harik, S ;

Barlogie, B ;

Tricot, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) :103-108

[5] Second Generation Proteasome Inhibitors in Multiple Myeloma [J].

Gozzetti, Alessandro ;

Papini, Giulia ;

Candi, Veronica ;

Brambilla, Corrado Zuanelli ;

Sirianni, Santina ;

Bocchia, Monica .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (07) :920-926

[6] Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models [J].

Li, Zhimin ;

Qiu, Yushi ;

Personett, David ;

Huang, Peng ;

Edenfield, Brandy ;

Katz, Jason ;

Babusis, Darius ;

Tang, Yang ;

Shirely, Michael A. ;

Moghaddam, Mehran F. ;

Copland, John A. ;

Tun, Han W. .

PLOS ONE, 2013, 8 (08)

[7] Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates [J].

Muscal, Jodi A. ;

Sun, Yongkai ;

Nuchtern, Jed G. ;

Dauser, Robert C. ;

McGuffey, Leticia H. ;

Gibson, Brian W. ;

Berg, Stacey L. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) :943-947

[8]

Petersen SL, 1999, AM J HEMATOL, V62, P228, DOI 10.1002/(SICI)1096-8652(199912)62:4<228::AID-AJH5>3.0.CO

[9]

2-3

[10]

Richardson PG, 2016, BLOOD, V127, P2693, DOI [10.1182/blood-2015-12686378, 10.1182/blood-2015-12-686378]

← 1 →